Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.85 Million GBP | 35.73% |
| 2022 | 4.31 Million GBP | 81.7% |
| 2021 | 2.37 Million GBP | -32.42% |
| 2020 | 3.51 Million GBP | 219.76% |
| 2019 | 1.09 Million GBP | -11.12% |
| 2018 | 1.23 Million GBP | -11.56% |
| 2017 | 1.39 Million GBP | 13.33% |
| 2016 | 1.23 Million GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.28 Million GBP | 0.0% |
| 2024 Q1 | 5.28 Million GBP | -9.61% |
| 2023 Q4 | 5.85 Million GBP | 0.0% |
| 2023 FY | 5.85 Million GBP | 35.73% |
| 2023 Q3 | 5.85 Million GBP | -15.43% |
| 2023 Q2 | 6.91 Million GBP | 0.0% |
| 2023 Q1 | 6.91 Million GBP | 60.49% |
| 2022 FY | 4.31 Million GBP | 81.7% |
| 2022 Q4 | 4.31 Million GBP | 0.0% |
| 2022 Q3 | 4.31 Million GBP | 57.47% |
| 2022 Q2 | 2.73 Million GBP | 0.0% |
| 2022 Q1 | 2.73 Million GBP | 15.39% |
| 2021 Q3 | 2.37 Million GBP | 3.6% |
| 2021 FY | 2.37 Million GBP | -32.42% |
| 2021 Q1 | 2.28 Million GBP | -34.77% |
| 2021 Q2 | 2.28 Million GBP | 0.0% |
| 2021 Q4 | 2.37 Million GBP | 0.0% |
| 2020 Q3 | 3.51 Million GBP | 207.61% |
| 2020 Q2 | 1.14 Million GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2020 FY | 3.51 Million GBP | 219.76% |
| 2020 Q4 | 3.51 Million GBP | 0.0% |
| 2019 FY | 1.09 Million GBP | -11.12% |
| 2018 FY | 1.23 Million GBP | -11.56% |
| 2017 FY | 1.39 Million GBP | 13.33% |
| 2016 FY | 1.23 Million GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|